文献速递关节外科

关节置换术后延长使用非甾体抗炎药与胃肠道出血风险

Risk of Gastrointestinal Bleeding With Extended Use of Nonsteroidal Anti-Inflammatory Drug Analgesia After Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2021-02-10

这项回顾性研究纳入2016至2018年50位术者完成的28,794例关节置换成人,术后90天内前瞻性识别胃肠道出血,主要分析用二元逻辑回归。结果显示74例(0.26%)发生胃肠道出血,中位8天;在5086例完整数据中,59.6%使用非甾体抗炎药(中位2周),但非甾体抗炎药使用与胃肠道出血无正相关,反而出血者 odds 更低;胃肠道出血与抗凝药、抗血小板药及较弱程度的阿司匹林相关。结论认为非甾体抗炎药未增加胃肠道出血,多数关节置换术后可安全处方。

要点

  • 关节置换术后90天内胃肠道出血发生率为0.26%(74/28,794),中位8天。
  • 非甾体抗炎药使用与胃肠道出血无正相关,出血者使用非甾体抗炎药的 odds 反而更低。
  • 胃肠道出血与抗凝药、抗血小板药及较弱程度的阿司匹林相关。

核心结论

  • 非甾体抗炎药与关节置换术后胃肠道出血无关联,多数患者术后可安全处方。
  • 胃肠道出血的最大 odds 见于消化性溃疡病患者及接受抗血小板、抗凝药者。
  • 年龄增加和双侧手术也与胃肠道出血相关。

研究设计与样本

  • 回顾性研究,纳入2016至2018年50位术者完成的28,794例关节置换成人。
  • 术后90天内胃肠道出血事件前瞻性识别,术后用药由患者电子问卷直接报告。
  • 主要分析采用二元逻辑回归,完整数据5086例纳入。

主要发现

  • 74例(0.26%)在术后90天内发生胃肠道出血,中位8天。
  • 完整数据5086例中59.6%使用非甾体抗炎药,中位 duration 2周(四分位距0-6周)。
  • 胃肠道出血者年龄更大(71.3 vs 67.0岁)、住院更长(2.1 vs 1.5天)、消化性溃疡史更多(10.8% vs 0.9%)。
  • 非甾体抗炎药使用与胃肠道出血无正相关,出血者使用非甾体抗炎药的 odds 更低。
  • 胃肠道出血与抗凝药、抗血小板药及较弱程度的阿司匹林相关。

临床怎么用

  • 多数关节置换术后患者可安全使用非甾体抗炎药镇痛,无需因胃肠道出血风险常规回避。
  • 对消化性溃疡病史、使用抗凝药或抗血小板药、高龄及双侧手术患者应重点评估胃肠道出血风险。

局限性

  • 证据等级为Level III。
  • 主要分析仅纳入5086例完整数据患者,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic nonsteroidal anti-inflammatory drug (NSAID) use is associated with gastrointestinal bleeding via inhibition of endogenous mucosal protection and platelet aggregation. This study aimed to determine whether extended NSAIDs after joint arthroplasty is associated with increased risk of gastrointestinal bleeding. METHODS: This was a retrospective study examining 28,794 adults who underwent joint arthroplasty by one of 50 surgeons from 2016 to 2018. Episodes of gastrointestinal bleeding within 90 days postoperatively were identified prospectively. Postoperative medications were reported directly by patients with electronic questionnaires. The primary analysis was performed using binary logistic regression. RESULTS: A total of 74 (0.26%) episodes of gastrointestinal bleeding occurred within 90 days (median 8 days) postoperatively. Of 5086 patients with complete data included in the primary analysis, 59.6% had used NSAIDs with median duration of 2 weeks (interquartile range, 0-6 weeks). Patients with gastrointestinal bleeding were significantly older (71.3 vs 67.0 years), required longer hospitalizations (2.1 vs 1.5 days), and more commonly had a history of peptic ulcers (10.8% vs 0.9%). However, there was no positive association between NSAID use and gastrointestinal bleeding. In fact, the odds of gastrointestinal bleeding were lower in patients taking NSAIDs. Gastrointestinal bleeding was associated with anticoagulants, antiplatelet agents, and, to a lesser extent, aspirin. CONCLUSION: NSAIDs were not associated with gastrointestinal bleeding and may be prescribed safely for a majority of patients after joint arthroplasty. The greatest odds of gastrointestinal bleeding occurred in patients with peptic ulcer disease and those who received antiplatelet and anticoagulation agents. Increasing age and bilateral surgery were also associated with gastrointestinal bleeding. LEVEL OF EVIDENCE: Level III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fleischman AN, Li WT, Luzzi AJ, et al. Risk of Gastrointestinal Bleeding With Extended Use of Nonsteroidal Anti-Inflammatory Drug Analgesia After Joint Arthroplasty. J Arthroplasty. 2021. PMID: 33642110. doi:10.1016/j.arth.2021.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。